BMY earnings & options Bristol-Myers Squibb Company
Implied vs actual, past reports
Definitions →Solid bars: the actual two-session reaction around each report (signed value printed below). Amber outlines: the move options priced beforehand — recorded from August 2026 onward, so older reports show the actual only.
Report-by-report record
| Report date | EPS act / est | Revenue act / est | Reaction | Implied | IV30 before → after |
|---|---|---|---|---|---|
| Jul 30, 2026 | 2.04 / 1.60 | 12.97B / 11.74B | +3.5% | not recorded | — |
| Apr 30, 2026 | 1.58 / 1.42 | 11.49B / 10.93B | +1.1% | not recorded | — |
| Feb 05, 2026 | 1.26 / 1.23 | 12.50B / 12.28B | +7.6% | not recorded | — |
| Oct 30, 2025 | 1.63 / 1.52 | 12.22B / 11.85B | +8.1% | not recorded | — |
| Jul 31, 2025 | 1.46 / 1.09 | 12.27B / 11.44B | -3.8% | not recorded | — |
| Apr 24, 2025 | 1.80 / 1.49 | 11.20B / 10.70B | -1.3% | not recorded | — |
| Feb 06, 2025 | 1.67 / 1.47 | 12.34B / 11.57B | -4.8% | not recorded | — |
| Oct 31, 2024 | 1.80 / 1.49 | 11.89B / 11.26B | +3.2% | not recorded | — |
| Jul 26, 2024 | 2.07 / 1.62 | 12.20B / 11.54B | +8.2% | not recorded | — |
| Apr 25, 2024 | -4.40 / -4.41 | 11.87B / 11.48B | -8.2% | not recorded | — |
| Feb 02, 2024 | 1.70 / 1.52 | 11.48B / 11.19B | -1.4% | not recorded | — |
| Oct 26, 2023 | 2.00 / 1.76 | 10.97B / 10.97B | -9.9% | not recorded | — |
| Jul 27, 2023 | 1.75 / 1.99 | 11.23B / 11.80B | -3.2% | not recorded | — |
| Apr 27, 2023 | 2.05 / 1.98 | 11.34B / 11.49B | -1.8% | not recorded | — |
| Feb 02, 2023 | 1.82 / 1.71 | 11.41B / 11.19B | +4.5% | not recorded | — |
| Oct 25, 2022 | 1.99 / 1.83 | 11.22B / 11.14B | +2.0% | not recorded | — |
Reaction = close before the report date to the close of the session after it (report timing is not published by the source; this two-session window contains the reaction either way). Implied moves are recorded live before each report from August 2026 onward — never reconstructed. Earnings data: Financial Modeling Prep.